Clinical trial
Circulating microRNAs as Novel Prognostic Biomarkers in Obese Preschoolers at Risk for Type 2 Diabetes in Adulthood
NCT02843139 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Circulating microRNAs as Novel Prognostic Biomarkers in Obese Preschoolers at Risk for Type 2 Diabetes in Adulthood
- Lead sponsor
- Nanjing Medical University
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2014
- Completion date
- March 31, 2016
- Enrollment
- 535 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
discriminate obese children at risk for diabetes.